The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rhe...

Por Navarro Coy, Nuria C, Brown, Sarah, Bosworth, Ailsa, Davies, Claire T, Emery, Paul, Everett, Colin C, Fernandez, Catherine, Gray, Janine C, Hartley, Suzanne, Hulme, Claire, Keenan, Anne-Maree, McCabe, Christopher, Redmond, Anthony, Reynolds, Catherine, Scott, David, Sharples, Linda D, Pavitt, Sue, Buch, Maya H
Publicado no BMC Musculoskelet Disord (2014)